Wellington Management Group
GPCR icon

Wellington Management Group’s Structure Therapeutics GPCR Stock Holding History

Wellington Management Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$396M Buy
7,379,433
+119,146
+2% +$5.27M 0.07% 256
2026
Q1 		$350M Buy
7,260,287
+138,303
+2% +$9.47M 0.07% 259
2025
Q4 		$495M Buy
7,121,984
+1,432,797
+25% +$58.5M 0.09% 206
2025
Q3 		$159M Sell
5,689,187
-1,186,582
-17% -$23.6M 0.03% 439
2025
Q2 		$143M Sell
6,875,769
-915,414
-12% -$20.1M 0.03% 440
2025
Q1 		$135M Buy
7,791,183
+5,569
+0.1% +$136K 0.03% 443
2024
Q4 		$211M Buy
7,785,614
+15,843
+0.2% +$562K 0.04% 358
2024
Q3 		$341M Buy
7,769,771
+221,851
+3% +$8.58M 0.06% 274
2024
Q2 		$296M Buy
7,547,920
+1,720,264
+30% +$70.6M 0.05% 300
2024
Q1 		$250M Buy
5,827,656
+1,455,330
+33% +$61.4M 0.04% 349
2023
Q4 		$178M Buy
4,372,326
+3,504,747
+404% +$201M 0.03% 418
2023
Q3 		$43.7M Buy
867,579
+657,310
+313% +$21.2M 0.01% 724
2023
Q2 		$8.74M Buy
210,269
+110,370
+110% +$3.09M ﹤0.01% 1135
2023
Q1 		$2.38M Buy
+99,899
New +$2.35M ﹤0.01% 1472

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Wellington Management Group's GPCR Position: Q2 2026 in Review

Wellington Management Group increased its Structure Therapeutics (GPCR) stake by 1.6% in Q2 2026, buying an estimated $5.27M and bringing the position to 7,379,433 shares worth $396M. The position accounts for 0.07% of the portfolio, ranked #256.

Wellington Management Group first reported a position in GPCR in Q1 2023 and has held it in 14 quarters since. The position peaked at $495M in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Wellington Management Group held 7,379,433 shares of Structure Therapeutics worth $396M as of Q2 2026.
  • Wellington Management Group bought 119,146 Structure Therapeutics shares in Q2 2026, an estimated $5.27M.
  • Structure Therapeutics made up 0.07% of Wellington Management Group's portfolio in Q2 2026, its #256 holding.
  • Wellington Management Group first reported a position in Structure Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • Wellington Management Group's Structure Therapeutics position peaked at $495M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.